1. Ametov AS, Demidova TYu, Kochergina II. The effi cacy of metformin in the treatment of type 2 diabetes. Medicinskij sovet. 2016;3:30-36. (In Russ.). DOI: 10.21518/2079-701X2016-3-30-37
2. Butrova S.A. Ot epidemii ozhireniya k epidemii saharnogo diabeta. Mezhdunarodnyj endokrinologicheskij zhurnal. 2013; 2(50):19-24. (In Russ.). eLIBRARY ID: 19060577
3. Kalinchenko SYu, Tyuzikov IA, Vorslov LO, Tishova YuA. Insulin Resistance and Male Reproductive Health: Pathogenic Interactions and Pathogenetic Pharmacotherapy. Effektivnaya farmakoterapiya. 2015;27:66-79. (In Russ.). eLIBRARY ID: 24126036
4. Saad F, Röhrig G, von Haehling S, Traish A. Testosterone Deficiency and Testosterone Treatment in Older Men. Gerontology. 2017;63(2):144-156. DOI: 10.1159/000452499
5. Biswas M, Hampton D, Newcombe RG, Rees DA. Total and free testosterone concentrations are strongly influenced by age and central obesity in men with type 1 and type 2 diabetes but correlate weakly with symptoms of androgen deficiency and diabetes-related quality of life. Clin Endocrinol (Oxf). 2012;76(5):665-673. DOI: 10.1111/j.13652265.2011.04196.x